AHIS, Alliance for Health Implementation Science

Initiatives / RAPID / Post-Acute COPD Evaluation Pilot

RespiratoryUtilization gapIn development

Post-Acute COPD Evaluation Pilot · ISP 2026005

After a breathing emergency, a clear next step.

Help adults seen for an acute breathing event complete needed COPD evaluation and connect to appropriate care, including evaluation for all guideline-recommended treatment options.

Program snapshot
Program ID
ISP 2026005
Initiative
RAPID · Follow-up after a respiratory event
Duration
16 weeks, including 12 weeks of active deployment
Geography
Memphis Mid-South and Los Angeles
Target
250 patients activated after an acute respiratory event
Status
In development

Why this program

The case for acting now.

1
The challenge

Patients seen for acute breathing events often leave without the follow-up testing needed to identify or better manage COPD.

2
The opportunity

A post-acute pathway can identify patients who need further respiratory evaluation and connect them to testing and appropriate care.

3
Why now

Patients with severe or inadequately managed COPD may be missed without systematic post-acute evaluation and care coordination.

Who it's for

The people this program serves.

Adults seen for an acute respiratory event who show signs of COPD, or of COPD that isn't well managed, and may benefit from further evaluation.

Priority indicators

Acute respiratory eventCOPD historyPrior exacerbationsCurrent treatmentPersistent symptoms

In their words

  • “As someone who had an acute breathing event, I want to understand what may have caused it.
  • “As someone with COPD, I want to know if my current treatment is enough.
  • “As someone who needs follow-up care, I want help getting connected so I don't get lost after the event.

The journey

Every step, from start to finish.

Each Implementation Support Program finds what works and scales it rapidly. Here is the path this one follows.

1Acute eventSeen for bronchospasmor another acuterespiratory event2AssessedCompletes apost-acuterespiratoryassessment3EvaluatedConnects to COPDevaluation4OptionsreviewedEvaluated for allguideline-recommendedtreatment options5ConnectedConnects toappropriate COPD care

What it involves

Barriers in, support out.

Barriers we address
  • Acute event treated as an isolated episode
  • Limited post-acute follow-up
  • Incomplete diagnostic testing
  • COPD underdiagnosis or undertreatment
  • Limited evaluation of treatment options
  • Fragmented care coordination
How the program helps
  • Post-acute respiratory assessment
  • Primary care connection
  • Pulmonology connection
  • Navigation support and discussion aids
  • Appointment help
Implementation hubs
2 or more acute-care hubs
Care partners
5 or more COPD care partners

What we measure

Every step, measured.

Primary measure
250
post-acute patients activated

Also measured

  • COPD evaluation rate of 25% or more
  • Connection-to-care rate of 50% or more
  • Post-acute identification and assessment
  • Evaluation of guideline-recommended treatment options
  • Time to evaluation

Timeline

16 weeks, from activation to impact report.

Week 2
Program activated
Acute-care workflows configured
Week 4
Preliminary results
First patients identified and assessed
Weeks 5 to 16
Implementation
Evaluations, eligibility reviews and connections to care
Completion
Impact report
Outcomes and recommendations for scale

Timing depends on partner alignment and on governance, protocol and IRB requirements.

Our commitments

Independent and non-promotional.

The post-acute respiratory assessment supports identification and connection to appropriate evaluation and care. It does not diagnose COPD or determine treatment eligibility, and AHIS does not promote any treatment.

Implementation Support Programs are sponsored separately from AHIS campaigns, and every sponsor is named here once an agreement is signed. The program follows a defined protocol, run under AHIS governance and the MONARCH operating standard for implementation measurement. Sponsors may help identify implementation challenges, populations or outcomes of interest. Design, governance and evaluation stay independent. Sponsors receive aggregate, de-identified results only.

Overseen by the AHIS Board in Phase 1 of AHIS governance, and by the Implementation Advisory Committee from Phase 2. Impact reports are shared publicly, including what didn't work.

How we stay independent

Get involved.

Become an acute-care implementation hub or a COPD care partner.

Schedule a discovery callIdentify a gapSee the initiative